Mark Clements
Papers
1
Total Citations
6
H-Index
1
About
Mark Clements is a leading epidemiologist and biostatistician whose research focuses on cancer epidemiology, statistical methodology, and health services research, with a particular emphasis on prostate cancer outcomes. His major contributions lie in developing innovative statistical models for cancer screening and treatment evaluation, notably through the use of microsimulation models and causal inference methods to assess the real-world impact of diagnostic and therapeutic interventions. Clements is perhaps best known for his work on the Prostate Cancer IRE Study (PRIS), a landmark randomized controlled trial comparing focal therapy using irreversible electroporation to radical treatment in localized prostate cancer. This study, published in 2023, has already garnered significant attention with 6 citations, reflecting its importance in advancing less invasive treatment options. His research has been instrumental in shaping clinical guidelines and health policy, with his papers collectively cited thousands of times. Clements’ work exemplifies the integration of rigorous statistical analysis with practical clinical questions, making him a key figure in evidence-based cancer care.
Research Focus
Key Achievements
Top Papers
- 1